Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-François Meritet

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Archives of Pathology & Laboratory Medicine|January 27, 2021
Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) PandemicPierre Sohier, Stéphanie Matar, Jean-François Meritet, et al.
European Cytokine Network|December 3, 2016
Production of TNF-alpha ex vivo is predictive of an immune response to flu vaccination in a frail elderly populationFrédéric Bloch, Bénédicte Charmeteau, Michael Tovey, et al.
Vaccine|July 26, 2015
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypesOphelie Godon, Alexei Evlachev, Maryline Bourgine, et al.
Genomics|February 28, 2002
Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsinsMichel Dron, Jean François Meritet, Françoise Dandoy-Dron, et al.
European Cytokine Network|June 28, 2007
Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factorsPierre Palmer, Michael G Tovey, Franck Raschilas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
Journal of Virology|August 21, 2002
Genetic diversity within human erythroviruses: identification of three genotypesAnnabelle Servant, Syria Laperche, Francis Lallemand, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 2, 2016
Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequencesAkouda Patassi, Sihem Benaboud, Dadja Essoya Landoh, et al.
Journal of Clinical Medicine|October 14, 2022
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 PatientsCamille Chenevier-Gobeaux, Morgane Ducastel, Jean-François Meritet, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Archives of Pathology & Laboratory Medicine|January 27, 2021
Histopathologic Features of Chilblainlike Lesions Developing in the Setting of the Coronavirus Disease 2019 (COVID-19) PandemicPierre Sohier, Stéphanie Matar, Jean-François Meritet, et al.
European Cytokine Network|December 3, 2016
Production of TNF-alpha ex vivo is predictive of an immune response to flu vaccination in a frail elderly populationFrédéric Bloch, Bénédicte Charmeteau, Michael Tovey, et al.
Vaccine|July 26, 2015
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypesOphelie Godon, Alexei Evlachev, Maryline Bourgine, et al.
Genomics|February 28, 2002
Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsinsMichel Dron, Jean François Meritet, Françoise Dandoy-Dron, et al.
European Cytokine Network|June 28, 2007
Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factorsPierre Palmer, Michael G Tovey, Franck Raschilas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 8, 2018
Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipientsStanislas Pol, Olivier Marion, Anaïs Vallet-Pichard, et al.
Journal of Virology|August 21, 2002
Genetic diversity within human erythroviruses: identification of three genotypesAnnabelle Servant, Syria Laperche, Francis Lallemand, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|June 2, 2016
Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lomé, Togo: Prevalence and molecular consequencesAkouda Patassi, Sihem Benaboud, Dadja Essoya Landoh, et al.
Journal of Clinical Medicine|October 14, 2022
Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 PatientsCamille Chenevier-Gobeaux, Morgane Ducastel, Jean-François Meritet, et al.
Pageof 3